Professional Documents
Culture Documents
Shock VT
Shock VT
SHOCK
DOOMSDAY
1
A Free sample background from www.powerpointbackgrounds.com
Slide 2
Vicken Y. Totten
Shock lecture
Thanks to David Cheng MD
And all who taught me
Definition
SHOCK:
inadequate organ
perfusion to meet
the tissue’s
oxygenation
demand
SYNDROME
Cells switch from aerobic to anaerobic metabolism
lactic acid production
Stages of shock
Compensated /Early Shock
– Vasoconstriction (renin & carotid sinus baroceptor
– Increase in HR and RR <- sympthatic activation)
– Normotensive usually <- (aldosterone/ADH Na+/h20
retention)
Decompensated / late Shock
– Cool, clammy , hypotenisve.
– Vital organ preservation
– Worsening LOC
– Continued increase in HR and RR <-----(Chemreceptor
respose to metabolic acidosis)
Irreversible-
– HR and RR drop Multi Organ Failure Impending death)
Symptoms of Shock
“Hypoperfusion can be
present in the absence of
significant hypotension.”
(Don’t only relay on BP for
diagnosisng shock)
-fccs course
8
A Free sample background from www.powerpointbackgrounds.com
Slide 9
Cardiovascular GI
– Myocardial – Ischemic bowel
depression Hepatic
– Vasogenic effects – Increased LFT’s, liver failure
Hematologic
Pulmonary – Neutropenia,
– ARDS Thrombocytopenia
Renal – DIC (Gm- > Gm+)
– ARF CNS
– coma
Circumferential
Subendocardial
Infarction due
to Shock
A Free sample background from www.powerpointbackgrounds.com
Slide 13
Shock
Lung
Remember
History and Physical often limited by patient’s
condition
Components:
– Blood (fluid)
– Heart (pump)
– Blood Vessels
(pipes)
Types of Shock
Hypovolemic (fluids)
Cardiogenic (pump)
Redistributive (pipes)
(septic, neurogenic, anaphylactic)
A Free sample background from www.powerpointbackgrounds.com
Slide 22
BP = SVR x CO
BP = blood pressure
CO = cardiac output (pump & fluids)
SVR = systemic vascular resistance (pipes)
An Approach to Shock
Low SVR
•Septic
shock
•Neurogenic (spinal cord injury) shock
•Anaphylaxis Shock
•Vasodilator (antihypertensive)
Posioning
• Pale
• Poor cap refill (>2 seconds)
• Cool arms/legs (>2 degree C difference)
• Thready pulses (narrow pulse pressure (incr DBP))
low CO
CO = HR x SV
CO = cardiac output
HR = heart rate
SV = stroke volume
HR Problems
BP = CO x SVR
CO = HR x SV
SV = preload & cardiac contractility-valve
Components of BP summary
Myocardial
Contractility
Blood
Pressure Heart Rate
Systemic Vascular
Resistance
Why Monitor?
Invasive :
Pulmonary artery catheter: CVP, PAWP, CO, SVR, DO2I,
VO2I, SvO2
Arterial catheter: ABP, Serum lactate, Base deficit
Diagnosis of Shock
Pulse Pressure=SBP-DBP
The difference between the systolic (fxn of
ejection fraction) and diastolic pressures (function
of SVR and distensibility (elastic recoil) of the aorta
Wide Narrow
– Normal 30-50 mmHg – May indicate an increase
– Commonly seen with fever, in vascular resistance with
anemia, exercise and decreased stroke volume
hyperthyroidism (ie aortic stenosis or
– AR (aortic regurgitation) is decreased intravascular
also a cause volume)
Invasive Markers
Global Markers
– Base Deficit
– Lactate
Regional Markers
– Gastric pH
– Sublingual CO2
Base Deficit
Base Deficit
Initial Lactate
Weil and Afifi. (Circulation 1970)
Gastric Intramucosal pH
Sublingual capnometry:
A new noninvasive measurement for diagnosis and
quantitation of severity of circulatory shock
Sublingual CO2
Sublingual capnometry:
A new noninvasive measurement for diagnosis and
quantitation of severity of circulatory shock
P SL CO2
provides a
prompt
indication of the
reversal of
tissue
hypercarbia
when
circulatory
shock is
reversed
A Free sample background from www.powerpointbackgrounds.com
Slide 49
INDICATIONS
– volume status
– cardiac status
COMPLICATIONS
– technical
– anatomic
– physiologic
Swan-Ganz Catheter
PLACEMENT
Standard Parameters
Measured Calculated
– Blood pressure – Mean BP
– Pulmonary A. – Mean PAP
pressure – Cardiac Index
– Heart rate – Stroke volume
– Cardiac Output index
– Stroke volume – SVRI
– Wedge pressure – LVSWI
– CVP – BSA
Why Index?
Body habitus and size is individual
PA Insertion
20
15
10
5
RA = 5 RV = 22/4 PA 19/10 PAOP(wedge) = 9
0
A Free sample background from www.powerpointbackgrounds.com
Slide 58
CVP
CVP of SVC at level of right atrium
pre-load “assessment”
normal 4 - 10 mm Hg
PAOP (wedge)
End expiration
Wedge adjustment with positive pressure
– Measured PAOP - ½ PEEP = “real PAOP”
Vascular Resistance
PULMONARY (PVR)
SYSTEMIC (SVR)
MAP - CVP
x 80 MPAP - PAOP
C0 x 80
CO
SVR = vasoconstriction
SVR = vasodilation
PVR = constriction
PE, hypoxia
Cardiac Cycle
PVR
CVP MAP
systemic
SVR
Definitions
CO/CI
SV/SVI
Hgb
SaO2
O2 consumption
AV shunts/fistulae
Oxycalculations
Break Time…
Goals of Shock
Resuscitation
Restore blood pressure
Parameters of Adequate
Resuscitation
Urine output (0.5 - 1.0 ml/kg/hr)
acceptable renal perfusion
Reversal of lactic acidosis (nl. pH)
improved perfusion
Normal mental status
adequate cerebral perfusion
-fccs course
73
A Free sample background from www.powerpointbackgrounds.com
Slide 74
ABC’s
– Maintain airway
– Decrease work of breathing & Optimize 02
– Circulation & Control Hemorrhage includes:
• Direct pressure
• Pressure points
• Fluids & Drugs
Management priorities
in hypoperfused states
Priority # Physiology to Intervention Parameter to target PAC Avoid
improve targets
1 Volume Fluids CVP 10-15 DO2 Low Sao2
See CXR
2 Pressure Vasopressor SBP? 100 or within 20-25 Low SV, DO2
torr High HR,
MBP ? 80 of patient's Nl Resistances
BP potency: Dopamine...NE…Vasopressin/Phenylephrine
Hypovolemia
Time
Outcomes of same vol. lost over diff. periods of time. Slow losses (III, IV)
allow compensations to take effect. Rapid loss (I, II) of same vol. is fatal
Hypovolemic Shock
Causes Signs
– hemorrhage cardiac output
– vomiting PAOP/CVP
– diarrhea SVR
– dehydration
– third-space loss
– burns
Treatment - Hypovolemic
Reverse hypovolemia & hemorrhage control
Crystalloid vs. Colloid
– 1 L crystalloid 250 ml colloid
• Watch for fluid overload by reassessing lung sounds
• 3:1 Rule (3cc crystalloid for 1cc bld loss)
• Watch for hyperchloremic metabolic acidosis when large volumes of NaCl are infused
• Best to give in 250 mL boluses in CHF followed by reassessment for another 250 cc bolus
– Colloids: (ex: albumin)
• Will increase osmotic pressure, watch for pulm edema
• Remain in vascular space longer (several hrs)
• NOT increase survival
prbc sooner than later
– 500 ml whole blood increases Hct 2-3%, 250ml PRBC’s increases Hct 3-4%
– Increases oxygen carrying capacity
– Used with acute hemorrhaging (mntn Hct 24% and Hgb 8g /dL)
Pressors?
Resuscitation
Transport times < 15 minutes showed
pre-hospital fluids were ineffective,
however, if transport time > 100 minutes
fluid was beneficial.
Role of PASG?
Higher mortality rate in penetrating thoracic, cardiac
trauma
Splinting role
Cardiogenic Shock
Mech
– defect in cardiac function (lost > 40% Fxn)
Signs
cardiac output
PAOP/CVP
SVR
left ventricular stroke work (LVSW)
Cardiogenic Shock
Symptoms of Cardiogenic
Shock
Skin: progressive peripheral vasoconstriction
results in cool, moist, pale skin with mottling
CHF Sx
– JVD, HJR, APE, pedal edema
Heart:
– Sounds: d/t enlargement and congestion you can
hear murmurs or S3 or S4
– Pulse: rapid rate and thready/weak pulse
BP: decreased BP and MAP
UO: decreases early d/t decreased renal
perfusion
Cardiogenic Shock
Assess for:
– Signs of heart failure
– Signs of tamponade
– Cardiac dysrrhythmia
– Myocardial infarction
– Tachycardia
– Muffled heart sounds or third heart sound
– Engorged neck veins with hypotension
– Dyspnea
– Edema in feet and ankles
Coronary Perfusion
Pressure
Shock
Increase oxygen supply to the heart
– Decrease O2 consumption (pain meds/sedation)
– Increase O2 delivery (Mech vent, reperfusion of the
coronary arteries)
Maximize the cardiac output
– Mntn normal rhythm (dysrhythmics, pacing,
cardioversion)
– Diastolic Vasopressors (dopamine, epi, norepi,
vasopressin)
– Improve myocardial contractility--Inotropes
• dobut and amrinone
Decrease the afterload (workload of the LV)
– IABP
– LVAD
Distributive Shock
Types
– Sepsis
– Anaphylactic
– Acute adrenal insufficiency
– Neurogenic
Signs
– ± cardiac output
PAOP
SVR
Anaphylaxis
Anaphylactic Shock
Rapid onset
Diffuse vasodilation mechanism from
histamine & bradykinin
Edema from increased capillary permeability
Bronchoconstriction
Symptoms
Onset within seconds and
progression to death in minutes
Cutaneous manifestations
– urticaria, erythema, pruritis, angioedema
Respiratory compromise
– stridor, wheezing, bronchorrhea, resp.
distress
Circulatory collapse
– tachycardia, vasodilation, hypotension
CNS
– apprehension->ams->coma
Diagnosis
Treatment
Remove the antigen
ABC’s
IV Fluids, O2, cardiac monitor, pulse ox
First line Rx:
– Epinephrine
– For severe bronchospasm, laryngeal edema, signs
of upper airway obstruction, respiratory arrest or
shock: IV epi
• 100 micrograms of 1:100,000 (place 0.1 mL of 1:1000 in
10 mL of NS, give over 5-10 min)
– If less severe, can give 0.3-0.5 mL 1:1000 SC
Treatment
2nd line:
– H1 blocker: Diphenhydramine 25-50 mg IV
– H2 blocker: Ranitidine 50 mg or Famotidine 20 mg IV.)
– Steroids (Methylprednisolone 125 mg IV or Prednisone
40-60 mg po)
– Albuterol
– For patients taking Beta-blockers with refractory
hypotension, think about glucagon
Septic Shock
SEPSIS
What is Sepsis?
SIRS Sepsis Severe Sepsis Septic
Shock
Sepsis is the combination of the Systemic
Inflammatory Response Syndrome (SIRS) & a
confirmed or presumed infectious etiology.
Severe Sepsis: SIRS criteria, source of infection and
infection-induced organ dysfunction or hypoperfusion
abnormalities (sepsis + lactic
acidosis/oliguria/AMS/etc.)
Septic Shock: SIRS criteria, source of infection, and
hypotension not reversed with fluid resuscitation and
associated with organ dysfunction or hypoperfusion
abnormalities
A Free sample background from www.powerpointbackgrounds.com
Slide 104
Septic Shock
Septic Shock TX
If MAP < 60
– Dopamine = 2 - 3 g/kg/min
– Norepinephrine = titrate (1-100 g/min)
Neurogenic Shock
Essential derangement:
paralysis of the
sympathetic chain which
controls vascular tone from
injury to thoracic or
cervical level spinal cord
injury.
Produces decreased SVR
from loss of vascular tone
and bradycardia from
unopposed
parasympathetic input to
SA node.
A Free sample background from www.powerpointbackgrounds.com
Slide 109
Caused by:
– Spinal cord injury loss of SNS
Massive venous pooling & arteriolar dilatation
Signs and Symptoms:
– Hypotension without tachycardia
– Warm pink skin from cutaneous vasodilation
– Low BP w/ minimal response to fluids
– Accompanying Neurologic deficit
Treatment of Neurogenic
Shock
Increase vascular tone and improve CO
– Increase preload with fluids
• CVP
• PAWP
– Increase vascular tone
• Vasopressors
– Maintain heart rate
• Treat bradycardia if symptomatic
– Maintain adequate oxygenation
• Watch with SCI because of the disruption of O 2 to the medulla
– Initiate therapy to prevent DVT
• Sluggish venous flow will increase risk factors
– Steroids (Methylprednisolone 30mg/kg over 15 min in first hour, then 5.4
mg/kg/hr x 23 hours)
• There are contradicting studies, all of which have flaw
The symptoms of neurogenic shock typically last 1-3 weeks
A Free sample background from www.powerpointbackgrounds.com
Slide 111
Obstructive Shock
Causes
– Cardiac Tamponade
– Tension Pneumothorax
– Massive Pulmonary Embolus
Signs
cardiac output
PAOP/CVP
SVR
Treatment
Needle decompression
Embolectomy / TPA
Adrenal Crisis
Distributive Shock
Causes
– Autoimmune adrenalitis
– Adrenal apoplexy = B hemorrhage or infarct
Vasopressor Agents?
Augments contractility, after preload established,
thus improving cardiac output.
Dopamine
Low dose (0.5 - 2 g/kg/min) = dopaminergic
SIDE EFFECTS
– tachycardia
– > 20 g/kg/min to norepinephrine
Dobutamine
-agonist
5 - 20 g/kg/min
Norepinephrine
Potent -adrenergic vasopressor
Epinephrine
- and -adrenergic effects
dose 1 - 10 g/min
Amrinone
Phosphodiesterase inhibitor, positive inotropic
and vasodilatory effects
vasopressin
Calcium Sensitisation by
Levosimendan
Enhanced
Enhanced contractility
contractility of
of myocardial
myocardial cell
cell
by amplifying
by amplifying trigger
trigger for
for contraction
contraction with
with
no
no change in total
change in total intracellular
intracellular Ca
Ca2+
2+
Clinical
Clinical trials
trials status
Endpoints?
Swan-guided resuscitation
– C.I. 4.5, DO2I 670, VO2I 166
Gastric pH
123
A Free sample background from www.powerpointbackgrounds.com
Slide 124